<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our previous study showed that gossypol (GOS) exhibits potent cytotoxic effects via <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induction against human colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells; however, the role of cyclooxygenase (COX)-2/<z:chebi fb="11" ids="26333">prostaglandin</z:chebi> (PG)E(2) on GOS-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is still unknown </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, 12-O-tetradecanoylphorbol-13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) addition significantly inhibited GOS-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in human colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> HT-29 cells in accordance with inducing COX-2 protein/PGE(2) production </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="6" ids="15702,53394">TPA</z:chebi> inhibition of GOS-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was blocked by adding protein kinase (PK)C inhibitors including <z:chebi fb="0" ids="15738">staurosporine</z:chebi> (ST), GF109203X (GF), and H7, characterized by the occurrence of cleaved caspase 3 proteins and a decrease in COX-2 protein/PGE(2) production in HT-29 cells </plain></SENT>
<SENT sid="3" pm="."><plain>The addition of COX activity inhibitors, including NS398 (NS), aspirin (AS), <z:chebi fb="0" ids="47381">diclofenac</z:chebi> (DI), and <z:chebi fb="0" ids="49662">indomethacin</z:chebi> (IN), suppressed <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> protection of GOS-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> with decreased <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) production in HT-29 cells </plain></SENT>
<SENT sid="4" pm="."><plain>Application of <z:chebi fb="0" ids="26338">PGE</z:chebi>(2), but not it analogs <z:chebi fb="0" ids="26337">PGD</z:chebi>(2), <z:chebi fb="0" ids="26346">PGJ</z:chebi>(2), or <z:chebi fb="0" ids="26340">PGF</z:chebi>(2Î±), protected HT-29 cells from GOS-induced DNA ladders, and the E-<z:chebi fb="0" ids="26347">prostanoid</z:chebi> (EP(1)) receptor <z:chebi fb="4" ids="48705">agonist</z:chebi>, 17PT-<z:chebi fb="0" ids="26338">PGE</z:chebi>(2), mimicked the protection induced by <z:chebi fb="0" ids="26338">PGE</z:chebi>(2), whereas the selective EP(2) receptor <z:chebi fb="4" ids="48705">agonist</z:chebi>, butaprostol (BUT), the EP(3) receptor <z:chebi fb="4" ids="48705">agonist</z:chebi>, sulprostol (SUL), and the EP(4) receptor <z:chebi fb="4" ids="48705">agonist</z:chebi>, <z:chebi fb="0" ids="26338">PGE</z:chebi>(1) alcohol (<z:chebi fb="0" ids="26338">PGE</z:chebi>(1)), showed no significant effects on GOS-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in HT-29 cells </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="26338">PGE</z:chebi>(2) 's protection against GOS-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was reversed by adding the selective EP(1) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, SC-19220 </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, GOS had an effective apoptotic effect on COLO205 colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells which expressed undetectable level of endogenous COX-2 protein than HT-29 cells, and the decreased COX-2 protein level via COX-2 siRNA or addition of COX-2 activity inhibitor NS significantly elevated GOS-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> in HT-29 cells </plain></SENT>
<SENT sid="7" pm="."><plain>COLO205-T cells were established through sustained <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> incubation of COLO205 cells, and COLO205-T cells showed a lower sensitivity to GOS-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> with increased COX-2 (not Bcl-2 and Mcl-1) protein than parental COLO-205 cells </plain></SENT>
<SENT sid="8" pm="."><plain>A decrease in COX-2 protein expression in COLO205-T cells by COX-2 siRNA transfection or enhanced GOS-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> according to <z:chebi fb="0" ids="53233">MTT</z:chebi> assay and DNA integrity assay </plain></SENT>
<SENT sid="9" pm="."><plain>The notion of COX-2/<z:chebi fb="0" ids="26338">PGE</z:chebi>(2) activation against GOS-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cells was demonstrated, and the combination of GOS and COX-2 inhibitors to treat colon <z:mp ids='MP_0002038'>carcinoma</z:mp> possesses clinical potential worthy of further investigation </plain></SENT>
</text></document>